Koninklijke Philips N.V. (NYSE:PHG) Q1 2023 Results Conference Call April 24, 2023 4:00 AM ET Company Participants Leandro Mazzoni - Head, Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer Conference Call Participants Hasan Al-Wakeel - Barclays Veronika Dubajova - Citi David Adlington - JPMorgan Delphine Le Louet - Societe Generale Robert Davies - Morgan Stanley Graham Doyle - UBS Falko Friedrichs - Deutsche Bank Sezgi Bice Oezener - HSBC Wim Gille - ABN ...

April 24, 2023 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Royal Philips (Translation of registrant's name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (Address of principal executive offices) Indicate by check ...

☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR As filed with the Securities and Exchange Commission on February 21, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY R ...

[SEC Filing Information](index=1&type=section&id=SEC%20Filing%20Information) Koninklijke Philips N.V.'s Form 6-K filing details with the SEC, covering registrant information and report authorization [Filing Details (Form 6-K, Registrant)](index=1&type=section&id=Filing%20Details%20%28Form%206-K%2C%20Registrant%29) This section details the filing of Form 6-K by Koninklijke Philips N.V. (Royal Philips) with the SEC, specifying its jurisdiction of incorporation and principal executive offices - Koninklijke Philips N.V. filed Form 6-K with the SEC on February 21, 2023[1](index=1&type=chunk) - The registrant is a foreign issuer from The Netherlands[1](index=1&type=chunk) [Report Content and Authorization](index=2&type=section&id=Report%20Content%20and%20Authorization) The Form 6-K comprises a press release titled "Philips publishes its Annual Report 2022" and is duly signed by the Chief Legal Officer - The report includes a press release titled "Philips publishes its Annual Report 2022", dated February 21, 2023[3](index=3&type=chunk) - The report was signed on behalf of Koninklijke Philips N.V. by M.J. van Ginneken, Chief Legal Officer, on February 21, 2023[3](index=3&type=chunk) [Press Release: Philips Publishes Annual Report 2022](index=3&type=section&id=Press%20Release%3A%20Philips%20Publishes%20Annual%20Report%202022) Announcement of Philips' 2022 Annual Report, covering performance, executive remuneration, and access details [Annual Report Publication Announcement](index=3&type=section&id=Annual%20Report%20Publication%20Announcement) Royal Philips announced the publication of its Annual Report 2022 on February 21, 2023, to be discussed at the upcoming AGM - Royal Philips published its Annual Report 2022 on February 21, 2023[4](index=4&type=chunk) - The Annual Report 2022 will be on the agenda for the Annual General Meeting of Shareholders (AGM) scheduled for May 9, 2023[4](index=4&type=chunk) [2022 Performance and Strategic Actions](index=3&type=section&id=2022%20Performance%20and%20Strategic%20Actions) Philips acknowledged 2022 as a "very disappointing year" and is implementing urgent actions to enhance patient safety, quality, and performance - Philips described 2022 as a **"very disappointing year"** for the company and its stakeholders[5](index=5&type=chunk) - The company is taking firm actions to strengthen patient safety and quality, improve execution, and step up performance with urgency in 2023[5](index=5&type=chunk) [Executive Remuneration Decisions](index=3&type=section&id=Executive%20Remuneration%20Decisions) The Supervisory Board and Board of Management waived all 2022 Annual Incentive pay-outs and 2020 Long-term Incentive grants due to disappointing performance - The 2022 Remuneration Report addresses shareholder sentiment and feedback received after the 2022 AGM[6](index=6&type=chunk) - Due to Philips' 2022 performance and stakeholder sentiment, the Supervisory Board and Board of Management waived all **2022 Annual Incentive (AI) pay-outs**[7](index=7&type=chunk) - The vesting of the **2020 Long-term Incentive (LTI) grant** for Board of Management members was also waived[7](index=7&type=chunk) [Access to Annual Report](index=3&type=section&id=Access%20to%20Annual%20Report) The Annual Report 2022 is available in ESEF format with the AFM, will be filed on Form 20-F with the U.S. SEC, and accessible online - Philips filed the Annual Report 2022 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF)[8](index=8&type=chunk) - The company expects to file the report on Form 20-F with the U.S. Securities and Exchange Commission (SEC) later on the same day[8](index=8&type=chunk) - The Annual Report 2022 is available online at www.results.philips.com, and printed copies can be obtained free of charge via email request[9](index=9&type=chunk) [About Royal Philips (Company Profile)](index=3&type=section&id=About%20Royal%20Philips%20%28Company%20Profile%29) Royal Philips is a leading health technology company focused on improving health and well-being through innovation, generating EUR 17.8 billion in sales in 2022 - Royal Philips is a leading health technology company focused on improving health and well-being through meaningful innovation[10](index=10&type=chunk) - The company provides personal health solutions for consumers and professional health solutions for healthcare providers, leveraging advanced technology and clinical/consumer insights[10](index=10&type=chunk) Royal Philips 2022 Key Figures | Metric | Value | | :----- | :---- | | 2022 Sales | EUR 17.8 billion | | Employees | Approximately 77,000 | | Global Presence | Sales and services in over 100 countries | [Forward-Looking Statements Disclaimer](index=3&type=section&id=Forward-Looking%20Statements%20Disclaimer) This section provides a standard disclaimer regarding forward-looking statements, noting inherent risks and uncertainties that could cause actual results to differ - The release contains forward-looking statements regarding Philips' financial condition, results of operations, business, and plans[11](index=11&type=chunk) - These statements inherently involve risk and uncertainty, as future events and circumstances could cause actual results to differ materially[11](index=11&type=chunk)

Koninklijke Philips N.V. (NYSE:PHG) Q4 2022 Earnings Conference Call January 30, 2023 4:00 AM ET Company Participants Leandro Mazzoni - Head, Investor Relations Abhijit Bhattacharya - Chief Financial Officer Roy Jakobs - Chief Executive Officer Shez Partovi - Chief Strategy and Innovation Officer Francis Kim - Head of Quality Wim Appelo - Chief Operations Officer Conference Call Participants Veronika Dubajova - Citi Hassan Al-Wakeel - Barclays David Adlington - J.P. Morgan Graham Doyle - UBS Falko Friedrich ...

Koninklijke Philips N.V. (NYSE:PHG) Q3 2022 Earnings Conference Call October 24, 2022 4:00 AM ET Company Participants Leandro Mazzoni - Head, Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Veronika Dubajova - Citi David Adlington - J.P. Morgan Graham Doyle - UBS James Vane-Tempest - Jefferies Falko Friedrichs - Deutsche Bank Sezgi Oezener - HSBC Wim Gille - ABN AMRO-ODDO Ed Ridley-Day - Redburn R ...

SECURITIES AND EXCHANGE COMMISSION REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 September 30, 2022 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant's name into English) The Netherlands (Jurisdiction of incorporation or organization) Washington, D.C. 20549 FORM 6-K Amstelplein 2 1096 BC Amsterdam – The Netherlands This report comprises a copy of the following press release: "Philips sh ...

Koninklijke Philips N.V. (NYSE:PHG) Q2 2022 Earnings Conference Call July 25, 2022 4:00 AM ET Company Participants Leandro Mazzoni - Head, IR Frans van Houten - CEO Abhijit Bhattacharya - CFO Roy Jakobs - Chief Business Leader, Connected Care Francis Kim - Chief Quality and Regulatory Officer Conference Call Participants Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Cazenove Julien Dormois - Exane BNP Paribas Graham Doyle - UBS James Vane-Tempest - Jefferies Falko Friedrichs - Deutsche Bank Ed Ridl ...

Q2 2022 Financial Performance - Philips' sales were 42 billion EUR, a 7% comparable decline, but a 3% decline excluding China, compared to Q2 2021[16] - China lockdowns significantly impacted Philips, with sales and order intake down by approximately 30% in China[16] - The adjusted EBITA margin was 52% of sales, compared to 126% in Q2 2021, primarily due to lower volumes and inflation[16] - Operating cash outflow was 306 million EUR, mainly due to temporarily higher inventories[16] Order Intake and Backlog - Order intake grew by 1%, and excluding China, order intake grew by 6%[16] - The company achieved solid order growth and an all-time high order book[21] Respironics Recall and Market Outlook - Philips Respironics expects to remediate around 55 million devices[47] - The company aims to have around 90% of the recall program units produced and shipped by the end of 2022[50] - Respironics sleep systems sales are projected to be approximately 02 billion EUR in 2022 and rebound to approximately 06 billion EUR by 2025, compared to 07 billion EUR in 2019[59] - Total Respironics sales are expected to be approximately 14 billion EUR in 2022 and reach approximately 21 billion EUR by 2025, compared to 21 billion EUR in 2019[59] Productivity and Cost Savings Initiatives - Philips is stepping up productivity initiatives to 05 billion EUR per year, aiming to deliver 20 billion EUR in the 2022-2025 period[88] - The company's Sustaining Engineering in India delivered 40 million EUR in savings in 2021 and is projected to deliver 60 million EUR in 2022[92] 2022 Outlook - Philips expects comparable sales growth of 6-9% in H2 2022[32] - The company anticipates an adjusted EBITA margin of approximately 10% for the full year 2022[32]

PHILIPS Royal Philips First Quarter 2022 results April 25, 2022 innovation #you Important information Forward-looking statements and other important information This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking sta ...